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ABSTRACT 
1,2-Dichloroethane (DCA) and ethylene dibromide (EDB) are among the top 15 
chlorinated aliphatic compounds on the Agency for Toxic Substances and Disease Registry’s 
Priority List of Hazardous Substances.  Co-contamination of groundwater with EDB and 1,2-
DCA resulted mainly from environmental releases of leaded gasoline; these compounds were 
added as lead scavengers.  A microcosm study by Henderson et al. (1) with soil and groundwater 
from a site contaminated with leaded gasoline demonstrated anaerobic biodegradation of EDB at 
a higher rate, and to a greater extent, than 1,2-DCA.  Both compounds were transformed mainly 
by dihaloelimination to ethene.  The objectives of this study were to measure maximum specific 
growth rates, half saturation coefficients, and lag times in enrichment cultures that use 1,2-DCA 
and EDB as terminal electron acceptors; and to evaluate if the presence of EDB has an effect on 
the kinetics of 1,2-DCA dehalogenation, and vice versa.  The effect of each compound on 
biodegradation rates of the other was evaluated at the high concentrations that may be found at 
industrial sites (e.g., >10 mg/L) and at the lower concentrations that have been reported at leaded 
gasoline sites.    
 Two enrichment cultures were developed; one was grown with EDB as its terminal 
electron acceptor, the other with 1,2-DCA.  The cultures dehalogenated weekly additions of 
approximately 24 mg/L of EDB and 1,2-DCA.  Lactate was provided as the electron donor and 
ethene was the predominant product from both compounds.  The enrichment cultures were used 
as a source of inoculum in experiments designed to measure the maximum specific growth rate 
(̂ߤ) and half saturation coefficient (KS) under different conditions:  with EDB and 1,2-DCA 
alone, using their respective enrichment cultures as inoculum; with EDB alone, using the 1,2-
DCA enrichment culture as inoculum; with 1,2-DCA alone, using the EDB enrichment culture as 
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inoculum; and with both compounds present together, in one case with the EDB enrichment 
culture as inoculum and another with the 1,2-DCA enrichment culture as inoculum.  Both 
enrichment cultures grew on either compound, even though the EDB enrichment had never 
previously been exposed to 1,2-DCA and vice versa.   
 Based on batch depletion experiments performed at high concentrations of 1,2-DCA and 
EDB, the maximum specific growth rate (̂ߤ) ranged from 0.19 to 0.58d-1for 1,2-DCA and from 
0.30 to 0.45 d-1 for EDB, with somewhat lower rates for EDB when the 1,2-DCA culture was 
used as the inoculum source.  Maximum transformation rates were 130 µM/d for 1,2-DCA and 
74 µM/d for EDB.  The half saturation coefficient for 1,2-DCA (5.7-15.7 mg/L, or 58-158 µM) 
was notably higher than what has been reported for polychlorinated ethenes (e.g., 1.6-3.9 µM for 
tetrachloroethene, 1.8-2.8 µM for trichloroethene, 1.8-1.9 µM for cis-dichloroethene) but similar 
in magnitude to vinyl chloride (63-602 µM); the higher KS values occurred when EDB was 
present along with 1,2-DCA.  The KS values for EDB were considerably lower than for 1,2-
DCA, with three of the four treatments at or below 15 µg/L (0.082 µM).  Nevertheless, the KS for 
EDB is two orders of magnitude higher than its maximum contaminant level (MCL; 0.00027 
µM).  In nearly all of the bottles used to measure ̂ߤ andKS, the rate of consumption slowed down 
faster than what was predicted by Monod kinetics.  At this transition point, EDB and 1,2-DCA 
levels reached a plateau or decreased at a considerably slower rate.  To account for this behavior, 
the Monod model was modified to include a transition concentration (St), which was subtracted 
from the substrate (S) concentration.  Without St in the model, the error associated with KSwas 
significantly higher for 1,2-DCA and EDB; the KSvalue for 1,2-DCA did not change 
substantially or increased somewhat; and the KSvalue for EDB was either unchanged or 
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decreased significantly.  St levels ranged from 12.9 to 127.5 µg/L for 1,2-DCA and 0.5 to 9.2 
µg/L for EDB. 
 Most importantly, in treatments when EDB and 1,2-DCA were both added, the EDB was 
always consumed first and adversely impacted the kinetics of 1,2-DCA utilization.  In separate 
experiments with 1,2-DCA provided alone, dechlorination of 1,2-DCA was interrupted by 
adding EDB at a concentration more than 100 times lower than the remaining 1,2-DCA; use of 
1,2-DCA did not resume until the EDB decreased close to its MCL.   
 Lag times prior to the onset of 1,2-DCA dechlorination ranged from 10-75 days, versus 
only 2-15 days for EDB.  The longest lag periods for 1,2-DCA occurred in treatments that were 
inoculated with the EDB enrichment culture.  Also, the presence of EDB with 1,2-DCA 
significantly increased the lag times prior to the onset of 1,2-DCA utilization.  However, the lag 
time for EDB was not impacted by the presence of 1,2-DCA (regardless of the inoculum source). 
 Batch experiments were also performed at lower 1,2-DCA and EDB concentrations, 
similar to those found near the source zone of leaded gasoline spills.  When the 1,2-DCA 
enrichment culture was provided as the inoculum, EDB was consumed first, reaching its MCL 
level in 11-22 days.  In the treatment with only 1,2-DCA added, its MCL was reached in 28-45 
days. With EDB present, biodegradation of 1,2-DCA started shortly after the EDB reached its 
MCL and the 1,2-DCA was consumed at an equivalent or slightly faster rate than in the 
treatment with 1,2-DCA alone, suggesting that prior exposure to EDB had a slightly beneficial 
impact.  With the EDB enrichment culture as inoculum, EDB was consumed first, in the 
presence or absence of 1,2-DCA.  The treatment with EDB alone was faster and reached the 
MCL first; however, the time required to reach the MCL was notably longer (34-38 days) than 
with the 1,2-DCA enrichment culture.  The lag time prior to the onset of 1,2-DCA 
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biodegradation was 49-61 days, considerably longer than for the 1,2-DCA enrichment culture.  
In the treatment with both compounds present, biodegradation of 1,2-DCA started around the 
time when EDB reached its MCL.  Overall, these experiments confirmed the preferential 
consumption of EDB over 1,2-DCA and that both contaminants can reach their respective MCL 
levels, regardless of the type of enrichment culture used as inoculum.   
 Evidence continues to accumulate for the need to monitor 1,2-DCA and EDB 
contamination of groundwater, especially at former leaded-gasoline site.  Corresponding interest 
in remediation approaches is likely to increase.  Bioaugmentation is a candidate approach for 
sites where monitored natural attenuation is infeasible.  Although considerable information is 
available on cultures that can dechlorinate 1,2-DCA, most have not been tested for their ability to 
debrominate EDB.  Of the two enrichment cultures evaluated in this study, the 1,2-DCA culture 
has the advantage of more rapid transition to 1,2-DCA after EDB is consumed.  Additional 
information is needed on the ability of enrichment cultures to dehalogenate 1,2-DCA and EDB in 
the presence of persistent fuel hydrocarbons.   
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CHAPTER ONE 
1.0 INTRODUCTION 
 
1.1 Overview 
According to the Agency for Toxic Substances and Disease Registry, ethylene dibromide 
(EDB) is the sixth highest ranked halogenated aliphatic compound on the Priority List of 
Hazardous Substances,and 1,2-dichloroethane (1,2-DCA) ranks fourteenth. EDB has the second 
lowest maximum contaminant level (MCL = 0.05 µg/L) in drinking water among all the organic 
compounds, after dioxin (2). The toxicity of 1,2-DCA is comparable to tetrachloroethene and 
trichloroethene, each with an MCL of 5.0 µg/L(3).  1,2-DCA is used as a precursor in the 
manufacture of vinyl chloride (VC) (4). EDB was widely used as a pesticide and soil fumigant 
until these applications were banned in the 1980s.  1,2-DCA and EDB are among the most 
frequently detected contaminants in drinking water when an MCL is exceeded(5). 1,2-DCA has 
been found at 570 National Priorities List sites (3), while EDB has been detected at 27 sites (2).  
The co-occurrence of EDB and 1,2-DCA in groundwater results mainly from 
environmental releases of leaded gasoline; these compounds were added as lead scavengers.  
Even though leaded gasoline has not been used for several decades, Falta et al. (6) demonstrated 
that EDB and 1,2-DCA have persisted at many sites that once had leaking storage tanks. Based 
on an evaluation of 1100 sites in South Carolina, 537 had EDB levels higher than its MCL.  The 
predicted maximum concentrations of EDB and 1,2-DCA in groundwater from a leaded gasoline 
release are 1.9 and 3.7 mg/L, respectively (7).  The co-occurrence of EDB and 1,2-DCA has also 
been reported for at least one industrial site, where concentrations of 1,2-DCA and EDB in the 
vicinity of the source area were approximately 100 mg/L and 10 mg/L, respectively (8). 
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 Under low redox anaerobic conditions, EDB and 1,2-DCA can be used as terminal 
electron acceptors via organohalide respiration.  The predominant pathway is dihaloelimination 
directly to ethene (Appendix-1).  Hydrogenolysis yields minor amounts of bromoethane from 
EDB and chloroethane from 1,2-DCA, both of which may be further reduced to ethane.  
Dehydrohalogenation yields minor amounts of vinyl bromide (VB) from EDB and VC from 1,2-
DCA, both of which may undergo hydrogenolysis to ethene.  Three types of microbes have been 
shown to use 1,2-DCA as a terminal electron acceptor, including Dehalococcoides (9-15), 
Dehalobacter (13, 16)and Desulfitobacterium (17-21). Use of EDB as a terminal electron 
acceptor has been demonstrated only with Dehalococcoides ethenogenesstrain195 (10, 15).  
Hydrogen serves as the electron donor.    
No information was found in the literature on Monod kinetic parameters (maximum 
specific growth rate and half saturation coefficient) for use of 1,2-DCA or EDB as terminal 
electron acceptors.  First order degradation rates have been reported, ranging from 0.44-18 yr
-1
 
for 1,2-DCA and 1.5-110 yr
-1
 for EDB (22).  Wilson et al. (23) estimated a half saturation 
coefficient for EDB of 490-1000 μg/L based on the similarity of its solubility to  VC; however, 
experimental measurements were not made.  In addition to a lack of information on the kinetics 
of 1,2-DCA and EDB utilization, no studies were found that evaluated the effect of each 
compound on the rate of biodegradation of the other, when they are present together.  A 
microcosm study by Henderson et al. (1) with soil and groundwater from a site contaminated 
with leaded gasoline demonstrated anaerobic biodegradation of EDB at a higher rate, and to a 
greater extent, than 1,2-DCA.  However, it was not clear if EDB inhibited use of 1,2-DCA, or if 
it was simply consumed at a higher rate.  At an industrial site where EDB and 1,2-DCA were 
present at levels above 10 mg/L, reductive dehalogenation of both compounds was observed  (8).  
3 
 
However, there was no indication that the co-occurrence of 1,2-DCA and EDB had an effect on 
the rate of dehalogenation of either compound.   
 
1.2ResearchObjectives 
The objectives of this study were to measure maximum specific growth rates, half 
saturation coefficients, and lag times in enrichment cultures that use 1,2-DCA and EDB as 
terminal electron acceptors; and to evaluate if the presence of EDB has an effect on the kinetics 
of 1,2-DCA dehalogenation, and vice versa.  The effect of each compound on biodegradation 
rates of the other was evaluated at the high concentrations that may be found at industrial sites 
(e.g., >10 mg/L) and at the lower concentrations that have been reported at leaded gasoline sites. 
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CHAPTER TWO 
2.0 MATERIALS AND METHODS 
 
2.1 Chemicals and Media 
 The purity and sources of chemicals used are as follows: EDB (99%) from Acros 
Organics; 1,2-DCA (99%) from Mallinckrodt; VC (99.5%) from Fluka; polymer grade ethene 
(99.9%) from Airgas; ethane (99.95%) and methane (99%) from Matheson; bromoethane (99%) 
from EMD Chemicals; chloroethane (99.7%) from Sigma-Aldrich; and VB (98%) from Pfaltz & 
Bauer. Sodium lactate syrup was obtained from EM Science (containing 58.8-61.2% sodium 
lactate; specific gravity = 1.31). All other chemicals were reagent grade.  
The mineral salts medium used to grow the enrichment cultures had the following 
constituents per liter of distilled, deionized water: 10 mL of phosphate buffer (52.5 g of K2HPO4 
per liter), 10 mL of salt solution (53.5 g of NH4Cl per liter, 4.7 g CaCl2·2H2O per liter, 1.8 g of 
FeCl2·H2O per liter), 2 mL of trace mineral solution (0.3 g of H3BO3 per liter, 0.2 g of 
ZnSO4·7H2O per liter, 0.75 g of NiCl2·6H2O per liter, 1.0 g of MnCl2·4H2O per liter, 0.1 g of 
CuCl2·2H2O per liter, 1.5 g of CoCl2·6H2O per liter, 0.02 g of Na2SeO3 per liter, 0.1 g of 
Al2(SO4)3·16H2O per liter, 1 mL of concentrated HCl per liter), 2 mL of MgSO4·7H2O solution 
(62.5 g/L), 1 mL of resazurin solution (1.0 g/L), 50 mL of filter-sterilized NaHCO3 solution 
(16.0 g/L), 10 mL of filter-sterilized yeast extract solution (5.0 g/L), 0.24 g of Na2S·9H2O and 
0.1448 g of FeCl2·H2O. The bicarbonate and yeast extract solutions were added after the medium 
was autoclaved and cooled. The container was then placed in an anaerobic chamber where the 
sulfide and ferric chloride were added. After dispensing the medium to serum bottles, they were 
removed from the chamber and the headspaces were purged with 70% N2/30% CO2. The pH was 
adjusted to approximately 7.0 with 8 M NaOH. 
5 
 
2.2Analytical Methods 
Volatile organic compounds were monitored by headspace analysis (24). 1,2-DCA, EDB, 
chloroethane, bromoethane, VC, VB, ethane, ethene, and methane were evaluated using a 
Hewlett-Packard 5890 Series II Gas Chromatograph, equipped with a flame ionization detector 
in conjunction with a column packed with 1% SP-1000 on 60/80 Carbopack-B (Supelco, Inc.). 
Nitrogen was used as the carrier gas. The temperature program was 60°C for 2 min, ramp at 
20°C/min to 150°C, ramp at 10°C/min to 185°C and hold for 5 min. Detection limits ranged 
from 0.2 to 6.0 µg/L for the halogenated compounds except for EDB, which had a detection limit 
of 23 µg/L. To quantify EDB at lower concentrations, headspace samples were analyzed using a 
Hewlett-Packard 5890 Series II Plus Gas Chromatograph equipped with an electron capture 
detector, as previously described (1). The detection limit for EDB with this method was 0.05 
µg/L.  Different syringes were used for the flame ionization detector and electron capture 
detector measurements of EDB to minimize the potential for carry-over of compound adsorbed 
to the syringe.    
 The gas chromatograph response to a headspace sample (0.5 mL) was calibrated to give 
the total mass of the compound (M) in that bottle (24). Assuming the headspace and aqueous 
phases were in equilibrium, the total mass present was converted to an aqueous-phase 
concentration with the following equation:  
 
   
 
       
 (2.1) 
where Clis the concentration in the aqueous phase (in micromolar units), M is the total mass 
present (µmol/bottle), Vlis the volume of the liquid in the bottle (L), Vgis the volume of the 
headspace in the bottle (L), and HCis the Henry’s law constant (gas concentration 
[mol/m
3
]/aqueous concentration [mol/m
3
]) at 23°C for 1,2-DCA (25), EDB (25), VC (24), 
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choroethane (24), ethene (26), and ethane (26), and at 25°C for methane (27), bromoethane (27), 
and VB (28).  
Protein was measured after lysing samples of the enrichment cultures, using a Compat-
Able
TM
 assay preparation reagent set and a BCA
TM
 protein assay kit (Pierce Chemical 
Company), following the manufacturer’s enhanced protocol (29). 
 
2.3 Enrichment Cultures 
Two anaerobic enrichment cultures were developed; one was provided with 1,2-DCA as 
the sole terminal electron acceptor and the other with EDB. The inoculum for both cultures was 
an enrichment culture that uses all of the chlorinated ethenes as terminal electron acceptors, with 
Dehalococcoides yields ranging from 6.8×10
5
 to 1.8×10
9
 gene copies/µmol Cl
-
 or Br- released 
(30). When provided with 1,2-DCA or EDB, the enrichment started dehalogenating these 
compounds at increasing rates. Sodium lactate was used as the electron donor for both cultures.  
Routine monitoring data for the enrichment cultures over 16-26 months is provided in 
Supplementary Information (Appendix-2), along with maintenance procedures. Ethene was the 
principal product from 1,2-DCA and EDB; trace levels of VC and VB were also present. Sodium 
hydroxide was added to keep the pH between 6.7 and 7.1. 
 
2.4Batch Kinetics at High Concentrations 
For the purposes of this study, 9.2-110 mg/L of 1,2-DCA and 17-86 mg/L of EDB were 
considered to be high concentrations.  The six treatments evaluated for the high concentration 
experiments are summarized in Table 2.1.  Two received 1,2-DCA, two received EDB, and two 
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received a mixture.  One half of the treatments were inoculated with the 1,2-DCA enrichment 
culture, the others with the EDB enrichment culture.   
Kinetic coefficients were determined in batch tests in 160 mL serum bottles. Experiments 
were initiated in an anaerobic chamber by combining 2 mL from one of the enrichment cultures 
with 98 mL of medium.  The serum bottles were then sealed with Teflon-faced red rubber septa 
and crimp caps. Outside the chamber the headspaces were purged (70% N2/30% CO2), the 
bottles were resealed, and the pH was adjusted (with NaOH) to 6.9-7.1. Serum bottles were 
incubated on a shaker table at room temperature (22-24°C) to provide continuous mixing, with 
the liquid in contact with the septa. Lactate was added so that the initial ratio of electron 
equivalents of donor to equivalents needed for dehalogenation was higher than 10. Repeated 
additions of lactate were made to ensure it remained in excess throughout the incubation period; 
acetate and propionate were the principal organic acids that accumulated (Appendix-3).  
The initial amount of 1,2-DCA added (using a water saturated solution or neat 
compound) was 9.6-26 µmol/bottle (9.2-25 mg/L). When it became apparent that a rapid rate of 
consumption had begun, repeated additions of 1,2-DCA were made in order to maintain 
saturation conditions.  The highest level of 1,2-DCA reached was 115 µmol/bottle (110 mg/L).  
Once the rate of 1,2-DCA consumption reached a maximum, no more was added and the rate of 
consumption was monitored until it decreased either to a transition level or below the detection 
limit.  The initial amount of EDB added was 9.1-21 µmol/bottle (17-39 mg/L).  The maximum 
amount reached was 46.8 µmol/bottle (86.2 mg/L); this was less than the maximum amount of 
1,2-DCA, since higher concentrations of EDB became inhibitory.  This pattern of adding 1,2-
DCA and EDB was adopted after trying other strategies, including addition of a single large dose 
at the outset.  However, especially with EDB, initial concentrations above approximately 100 
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mg/L were inhibitory (Appendix-4).  By starting at a lower initial concentration and increasing 
the amounts added over time, the cultures were able to acclimate.    
 Batch experiments were performed in triplicate and were repeated at least three times, 
over a 17-month period.  Of these, at least two bottles for each treatment exhibited high rates of 
EDB and/or 1,2-DCA consumption.   
Maximum growth rates (   , d-1) based on 1,2-DCA and EDB consumption were 
determined using a method adapted from the respirometic procedure of Brown et al. (31). 
Assuming that endogenous decay is negligible during periods of exponential growth, the rate of 
substrate utilization can be calculated as: 
 
 
  
  
 
 
 
 
  
    
 (2.2) 
where S is the substrate concentration (mg/L), Y is the yield (mg biomass/mg 1,2-DCA or EDB), 
X is the biomass concentration (mg/L), and KS is the half saturation coefficient (mg/L of 1,2-
DCA or EDB).  In this study, maximum growth rates were determined based on the cumulative 
amount of terminal electron acceptor consumed (i.e., 1,2-DCA and EDB), or Su(mg 1,2-DCA or 
EDB per liter).  X can be expressed as the initial biomass concentration (Xo) plus the amount 
formed based on the yield (expressed in terms of electron acceptor consumption).  Making these 
substitutions, equation 2.2 becomes: 
    
  
 
        
 
 
  
    
 (2.3) 
Under batch conditions, when the substrate concentration is high relative to the half saturation 
constant (i.e., S>>KS) and the initial biomass concentration is low relative to the new amount 
formed (i.e., SuY >>Xo), equation 2.3 simplifies to: 
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     (2.4) 
Separating variables and integrating equation 2.4 results in: 
         (2.5) 
 Maximum growth rates were determined from the slope for equation 2.5, based on the 
cumulative amount of EDB and 1,2-DCA consumed during the exponential phase of activity.  
Averages and standard deviationswere calculated based on the results from 2-8 serum bottles per 
treatment.   
 Monod half saturation coefficients (KS), transition concentrations (St, mg 1,2-DCA or 
EDB per liter), and maximum substrate consumption rates (  , mg 1,2-DCA or EDB per liter per 
day) were determined in the same serum bottles used to measure the maximum growth rates. 
Following the final addition of EDB or 1,2-DCA, the rate of consumption was monitored until 
the level reached a transition concentration or decreased below detection. Based on similar batch 
depletion studies with VC, mass transfer between the headspace and liquid phases was assumed 
not to be limiting, so that monitoring of the headspace represented the aqueous phase 
concentrations for all of the halogenated volatile compounds (32). Sufficient amounts of 1,2-
DCA and EDB were consumed to ensure that the biomass levels reached steady state, i.e., so that 
the growth rate equaled the decay rate. This was confirmed by protein measurements (Appendix-
11).  
 Since biomass concentrations reached a maximum (  ) and   /Y is a constant (i.e., the 
maximum specific substrate removal rate), then the maximum reaction rate (  ) is: 
 
   
  
 
   (2.6) 
Substituting equation 2.6 into equation 2.2 yields: 
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 (2.7) 
 In nearly all of the bottles that received high doses of 1,2-DCA and/or EDB, the rate of 
consumption slowed down faster than what is predicted by equation 2.7.  At this transition point, 
EDB and 1,2-DCA levels reached a plateau or decreased at a considerably slower rate.  To 
account for this behavior, equation 2.7 was modified to include a transition concentration (St): 
 
 
  
  
  
         
         
 (2.8) 
 KS, St and   were determined by a weighted, nonlinear least-squares method by fitting of 
batch depletion data for 1,2-DCA and EDB to equation 2.8 using the software AQUASIM (32-
33).  Each data point was weighted with the inverse of the substrate concentration.  The fitting 
process was initiated with the simplex optimization method and then fully optimized by the 
secant method, which reports the standard deviation of each parameter(32). Equation 2.8 was fit 
to data from each serum bottle to obtain initial estimates of KS, St and  .  Data from all bottles 
within a treatment were then pooled and, using the average results from individual bottles as a 
starting point, equation 2.8 was fit simultaneously to determine KS and St; values for   remained 
bottle-specific.   
 The lag time for each bottle was the time interval from day zero till the onset of 
exponential growth; averages and standard deviations were calculated based on the lag times in 
individual bottles. 
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2.5Biodegradation of 1,2-DCA and EDB at Concentrations Representative of Leaded 
Gasoline Spills 
For the purposes of this study, 1,2-DCA and EDB concentrations less than or equal to 4.5 
mg/L and 2.2 mg/L, respectively, were considered to be representative of the levels found near 
the source zones at leaded gasoline releases (7).  Separate experiments were performed at these 
lower concentrations in the same manner as described above, except that only a single addition 
of 1,2-DCA and/or EDB was made.  Lactate was maintained in excess. 
 
CHAPTER THREE 
3.0 RESULTS 
 
3.1 High Concentrations of 1,2-DCA and EDB 
 Representative results for the batch experiments are shown in Figure 3.1.  The y-axes are 
expressed in µmol per bottle, in order to directly reveal the stoichiometry of the parent 
compounds and daughter products.  Consumption of 1,2-DCA (initial amount = 21.6 
µmol/bottle, or an aqueous phase concentration of 20.7 mg/L) in treatment A (inoculated with 
the 1,2-DCA enrichment culture; Fig. 3.1a) started after a lag period of 10 days. Ethene was the 
predominant product, amounting to 76.1 ± 7.2% of the 1,2-DCA consumed; the highest average 
VC accumulation was 0.61% of the 1,2-DCA consumed (Appendix-5). Methanogenesis was 
partially inhibited until 1,2-DCA levels decreased to below approximately 5 µmol/bottle (4.8 
mg/L).  Consumption of EDB (initial amount = 10.2 µmol/bottle, or an aqueous phase 
concentration of 18.8 mg/L) in treatment F (inoculated with the EDB enrichment culture; Fig. 
3.1b) started after a lag period of approximately 5 days.  Ethene was the predominant product, 
amounting to 75.6 ± 9.2% of the EDB consumed; the highest average VB accumulation was 
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0.052% of the EDB consumed (Appendix-5). Methanogenesis was suppressed for the duration of 
the test.  Results for 1,2-DCA inoculated with the EDB enrichment culture (treatment C) and 
EDB inoculated with the 1,2-DCA enrichment culture (treatment E) were similar to those shown 
in Figure 3.1a and 3.1b, respectively (Appendix-6). This indicated that the 1,2-DCA enrichment 
culture had no difficulty in switching to EDB as the terminal electron acceptor, and vice versa.   
 For treatment B, in which 1,2-DCA and EDB were added together and inoculated to the 
1,2-DCA culture, EDB consumption started first, following a lag period of approximately 10 
days (Fig. 3.1c). 1,2-DCA consumption did not start until EDB decreased to close to its detection 
limit.  The pattern of EDB and 1,2-DCA additions was similar to those used when the individual 
compounds were added (Fig. 3.1a and 3.1b). Ethene was the predominant product of both 
compounds; the highest average VB accumulation was 0.072% of the total EDB consumed and 
the highest average VC accumulation was 0.40% of the 1,2-DCA consumed (Appendix-5). 
Methanogenesis was inhibited throughout the entire incubation period.  
 Similar results were obtained for the treatment D, in which 1,2-DCA and EDB were 
added simultaneously and the EDB enrichment culture was used as the inoculum (Fig. 3.1d).  
EDB consumption started first, following a lag period of approximately 10 days. 1,2-DCA 
consumption started approximately 45 days after EDB decreased below 15 µg/L.  Ethene was the 
predominant product of both compounds; the highest average VC accumulation was 0.64% of 
the 1,2-DCA consumed and the highest average VB accumulation was 0.093% of the EDB 
consumed (Appendix-5). Methanogenesis was only inhibited by the presence of EDB.  
Water and medium control results demonstrated that the consumption of 1,2-DCA and 
EDB in the serum bottles was due to biotic processes. There was no statistically significant loss 
of either compound over incubation periods similar to those shown in Figure 3.1 (Appendix-7). 
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 Based on results from the time periods when there was an exponential increase in the rate 
of 1,2-DCA and EDB consumption, the data were fit to equation 2.5 to determine the maximum 
growth rates.  Representative results are shown in Figure 3.2a for the same bottles shown in 
Figure 3.1 (complete results are in Appendix-8) and average results for all treatments are shown 
in Figure 3.3a.  The maximum growth rate on 1,2-DCA was equivalent for the treatments 
inoculated with the 1,2-DCA enrichment culture, with or without EDB added (A and B, 
respectively), and in the treatment inoculated with the EDB culture (treatment C). The treatment 
inoculated with the EDB culture that received EDB and 1,2-DCA together had a lower growth 
rate on 1,2-DCA (treatment D) (Scheffe’s test, α=0.05), suggesting that prior growth on EDB 
slowed the subsequent rate of growth on 1,2-DCA.  However, it should be noted that only two 
bottles were evaluated for treatment D, compared to 4-8 bottles for treatments A, B, and C.  
There was no significant difference among the maximum growth rates for EDB, i.e., B, D, E and 
F (Fig. 3.3a) (Scheffe’s test, α=0.05).  Overall, the average growth rate on 1,2-DCA for all 
treatments (0.50 d
-1
) was significantly higher than that for EDB (0.38 d
-1) (Student’s t-test, 
α=0.05). 
 Figure 3.2b and 3.2c show representative batch depletion data that were fit to equation 
2.8, providing KS and St. During this period of incubation, protein concentrations did not change 
(Appendix-11), consistent with the assumption that biomass levels remained constant over this 
interval.  Figure 3.2b shows the model fit for the treatment with 1,2-DCA as the electron 
acceptor, corresponding to Figure 3.1a and 3.1c.  Figure 3.2c is for bottles that received EDB as 
the electron acceptor; results for the full duration of the incubation period for these bottles are in 
Appendix-6.  Average results for KS are presented in Figure 3.3b; the values for 1,2-DCA are an 
order of magnitude higher than for EDB.  When both compounds were added, the Ks value for 
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1,2-DCA increased significantly, suggesting an inhibitory caused effect for EDB.  The lowest KS 
value for EDB occurred when only EDB was added and the 1,2-DCA enrichment culture served 
as the inoculum (treatment E), while the highest was for EDB alone and the EDB culture was the 
inoculum (treatment F).  The presence of 1,2-DCA along with EDB did not increase the KS for 
EDB when the 1,2-DCA culture was the inoculum (i.e., treatment B versus E), although the 
standard deviations exceed the averages.  The presence of 1,2-DCA along with EDB decreased 
the KS for EDB when the EDB culture was the inoculum (i.e., treatment D versus F), suggesting 
that 1,2-DCA had a stimulatory effect.   
 Similar to KS, the transition levels for 1,2-DCA were one to two orders of magnitude 
higher compared to EDB (Fig. 3.3c.).  The most notable influence on St for 1,2-DCA occurred in 
the treatment with both compounds added and inoculated with the EDB enrichment culture 
(treatment D), which was significantly higher than when only 1,2-DCA was added (treatment C).  
With EDB, the standard deviations for St were higher.  Nevertheless, the transition level was 
significantly lower for EDB alone when the EDB culture was the inoculum (treatment F) versus 
the 1,2-DCA culture (treatment E) (Student’s t-test, α=0.05).  For most of the treatments, once 
the transition level was reached, little or no additional dehalogenation occurred.  However, 18% 
of the bottles in treatments A and 33% in treatment C did eventually reach the MCL for 1,2-
DCA; 25% of the bottles in treatment F eventually reached MCL for EDB. 
 The maximum substrate utilization rates (  ) for 1,2-DCA and EDB were 12.7 (±5.3) and 
13.9 (±5.8) mg/L/d, respectively (Appendix-9).  The coexistence of 1,2-DCA and EDB did not 
significantly change   for either compound, with one exception:  When the EDB enrichment 
culture served as the inoculum, the presence of EDB decreased the   for 1,2-DCA by 45% 
(Student’s t-test, α=0.05).   
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The presence of EDB with 1,2-DCA significantly increased the lag times for 1,2-DCA 
(i.e., treatment A versus B and C versus D; Fig. 3.3d).  In addition, the lag time for 1,2-DCA was 
longer in the treatments inoculated with the EDB enrichment culture (i.e., treatment A versus C 
and B versus D).  Conversely, the lag time for EDB was not impacted by the presence of 1,2-
DCA (regardless of the inoculum) and was equivalent to the lag time for 1,2-DCA in treatment 
A. 
3.2Effect of Low EDB Levels on 1,2-DCA 
The results in Figure 3.1c and 3.1d indicated that biodegradation of 1,2-DCA was 
inhibited until EDB levels decreased close to the detection level.  To verify this phenomenon, 
three sets of duplicate serum bottles were prepared with 1,2-DCA as the sole substrate and the 
1,2-DCA enrichment culture as inoculum (2% v/v), in the same manner described for the batch 
kinetic tests.  All bottles received three additions of 1,2-DCA; Figure 3.4 shows what occurred 
during the third addition.  The y-axes on Figure 3.4 are in terms of aqueous phase concentrations, 
since daughter products are not shown.  A comparatively small amount of EDB was added to 
two of the sets (i.e., 370 µg/L EDB in Fig. 3.4b and 645 µg/L in Fig. 3.4c) when the 1,2-DCA 
amount remaining had decreased by 32-45%.  Addition of these low levels of EDB immediately 
decreased the rate of 1,2-DCA consumption, while the EDB was consumed at a high rate.  As the 
EDB level decreased close to its MCL, a high rate of 1,2-DCA consumption resumed.  This 
demonstrated that EDB was used by the cultures to the exclusion of 1,2-DCA.  There was no 
apparent impact of the short-term exposure to EDB on the subsequent rate of 1,2-DCA 
consumption. 
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3.3Biodegradation of 1,2-DCA and EDB at Concentrations Representative of Leaded 
Gasoline Spills 
Figure 3.5 presentsthe results for batch tests started at 1,2-DCA and EDB concentrations 
similar to those found near the source zone of leaded gasoline spills.  With the 1,2-DCA 
enrichment culture as inoculum, EDB was consumed first, reaching its MCL in 11-22 days (Fig. 
3.5a).  The presence of 1,2-DCA along with EDB had mixed effects on the rate of EDB 
biodegradation; in two of the three replicates, bottles with 1,2-DCA reached the MCL for EDB 
first, while in one of the bottles EDB consumption was slower than in the bottles with only EDB 
present.  In the treatment with only 1,2-DCA, the lag time was approximately 9-14 days before 
the onset of biodegradation, with the MCL reached by day 28-45. With EDB present, 
biodegradation of 1,2-DCA started shortly after the EDB reached its MCL and the 1,2-DCA was 
consumed at an equivalent or slightly faster rate than in the treatment with 1,2-DCA alone, 
suggesting that prior exposure to EDB had a slightly beneficial impact.   
With the EDB enrichment culture as inoculum, EDB was consumed first, in the presence 
or absence of 1,2-DCA (Fig. 3.5b).  The treatment with EDB alone reached the MCL first; 
however, the time required to reach the MCL was notably longer (34-38 days) than with the 1,2-
DCA enrichment culture.  The lag time prior to the onset of 1,2-DCA biodegradation was 49-61 
days, considerably longer than for the 1,2-DCA enrichment culture (Fig. 3.5a).  In the treatment 
with both compounds present, biodegradation of 1,2-DCA started around the time when EDB 
reached its MCL.  Overall, lag times for the onset of 1,2-DCA and EDB biodegradation at the 
lower initial concentrations were equivalent to or shorter than at the concentrations used in the 
higher concentration kinetic tests (Fig. 3.3c). 
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CHAPTER FOUR 
4.0  DISCUSSION 
The results of this study provide maximum specific growth rates and half saturation 
coefficients for 1,2-DCA and EDB, when the compounds were available individually and in 
mixtures, using enrichment cultures that were grown on each compound.  EDB was used in 
preference to 1,2-DCA when both compounds were present.  This is consistent with the 
observation made by Henderson et al. (34) based on a microcosm study of a site contaminated 
with leaded gasoline.  The free energy change for EDB dehalogenation to ethene is slightly better 
than for 1,2-DCA, although the magnitude of the difference (6.7 kJ/mole) is not necessarily a 
compelling explanation for the preference of debromination over dechlorination (34).  
Regardless, reductive debromination is more favorable than dechlorination for other types of 
halogenated organics, not just dihaloethanes.  For example, polybrominated biphenyls are used 
in preference to polychlorinated biphenyls (35).  This preference was especially apparent when 
dechlorination of 1,2-DCA was interrupted by adding EDB at a concentration more than 100 
times lower than the 1,2-DCA; use of 1,2-DCA did not resume until the EDB decreased close to 
its MCL (Fig. 3.4).   
The maximum specific growth rates for 1,2-DCA ranged from 0.19 to 0.58 d
-1
, which is 
similar to the 0.21 d
-1
 rate for Desulfitobacterium dichloroeliminans strain DCA1, based on its 
yield and maximum utilization rate (21).  The maximum specific growth rates for EDB ranged 
from 0.30 to 0.45 d
-1
; no previous studies were found that measured   for EDB.  Similar growth 
rates have been reported for cis-1,2-dichloroethene (e.g., 0.17-0.26 d
-1
, calculated from the yield 
and maximum utilization rate reported by Yu et al. (36)).  A number of studies report maximum 
dechlorination rates for 1,2-DCA; e.g., 150 µM/d for an enrichment culture containing 
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predominantly Dehalobacter(16), 630 µM/d for Dehalococcoides ethenogenes strain 195 (9), 
and 1300 µM/d for an enrichment containing Desulfitobacterium dichloroeliminans strain DCA1 
(21).  The 1,2-DCA transformation rate observed during this study (  ) was 130 µM/d.  A 
maximum debromination rate of 80 µM/d for EDB was estimated from Tandoi et al. (37); this is 
similar to the rate observed in this study (74 µM/d).   
No previous studies were found that reported KS values for 1,2-DCA or EDB.  In general, 
the values measured in this study for 1,2-DCA (58-158 µM) are notably higher than what has 
been reported for polychlorinated ethenes (e.g., 1.6-3.9 µM for tetrachloroethene, 1.8-2.8 µM for 
trichloroethene, 1.8-1.9 µM for cis-dichloroethene) but similar in magnitude to VC (63-602 µM), 
as reported by Yu et al. (38).  The KS values measured for EDB are considerably lower, with 
three of the four treatments at or below 0.082 µM.  Nevertheless, the KS for EDB is two orders of 
magnitude higher than its MCL (0.00027 µM).   
Use of a transition concentration (St) in the Monod substrate depletion equation allowed 
for a better fit of the model at low concentrations of 1,2-DCA and EDB.  During the experiments 
to determine   and KS, the rate of 1,2-DCA and EDB consumption slowed or stopped in a 
majority of the bottles before the MCL was reached.  St levels ranged from 12.9 to 128 µg/L for 
1,2-DCA and 0.50 to 9.2 µg/L for EDB.  When the 1,2-DCA and EDB depletion date were fit to 
equation 2.7 (i.e., without St), there was a notable increase in the error associated with KS, while 
the value of KS for 1,2-DCA did not change substantially or increased somewhat; the KS value 
for EDB was unchanged for treatment F and increased 2.6 to 336-fold for treatments B, D and E 
when St was not included (Appendix-10).  Thus, inclusion of St had a notably greater influence 
on the KS for EDB.   
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Coleman et al. (39) used a similar modification to an equation for predicting oxygen 
consumption during aerobic biodegradation of VC, although in their experiments a true threshold 
existed.  In our study, St was not a true threshold, since 1,2-DCA and EDB levels continued to 
decrease at a slow rate in some instances.  The onset of a slower rate of consumption and/or the 
cessation of dehalogenation activity appeared to be a consequence of the high concentrations of 
1,2-DCA and EDB that were added, since in the lower concentration experiment, all of the 
replicates reached the MCL for both compounds (Fig. 3.5).  This suggests that reaching the MCL 
may not reliably occur in the vicinity of a source zone for a release of neat material.  However, 
as the concentration decreases away from the source area, the likelihood of reaching the MCL 
should improve, provided that the system remains anaerobic.     
One of the concerns with cultures that dechlorinate 1,2-DCA is the potential for 
accumulation of VC.  In this study, VC accumulation reached 7.6 µM (0.40-0.68% of the total 
1,2-DCA consumed), although subsequent decreases in VC occurred with continuing incubation 
(Fig. 3.1).  No accumulation of VC was reported in laboratory studies with Desulfitobacterium 
dichloroeliminans strain DCA1 (20-21)), although 20-30 µM accumulation occurred in a pilot-
scale bioaugmentation test (17).  VB accumulation was lower than VC (1.3 µM, or 0.05-0.09% 
of the total EDB consumed) and it too decreased over time (Fig. 3.1).      
Evidence continues to accumulate for the need to monitor 1,2-DCA and EDB 
contamination of groundwater, especially at formed leaded-gasoline sites (23).  Corresponding 
interest in remediation approaches is likely to increase.  Bioaugmentation is a candidate approach 
for sites where monitored natural attenuation is infeasible.  Although considerable information is 
available on cultures that can dechlorinate 1,2-DCA, most have not been tested for their ability to 
debrominate EDB.  Of the two enrichment cultures evaluated in this study, the 1,2-DCA culture 
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has the advantage of more rapid transition to 1,2-DCA after EDB is consumed (Fig. 3.5).  
Additional information is needed on the ability of enrichment cultures to dehalogenate 1,2-DCA 
and EDB in the presence of persistent fuel hydrocarbons. 
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CHAPTER FIVE 
5.0  CONCLUSIONS 
Based on the results of this study, the following conclusions were reached: 
 The cultures enriched with either EDB or 1,2-DCA were able to use either compound as a 
terminal electron acceptor.  Biodegradation occurred predominantly via dihaloelimination 
to ethene.  
 Maximum specific growth rates (  ) ranged from 0.19 to 0.58 d-1for 1,2-DCA and from 
0.30 to 0.45 d
-1
 for EDB.   
 Maximum transformation rates were 130 µM/d for 1,2-DCA and 74 µM/d for EDB.   
 The half saturation coefficient for 1,2-DCA (5.7-15.7 mg/L, or 58-158 µM) was 
considerably higher than the KS values for EDB, with three of the four treatments at or 
below 15 µg/L (0.082 µM).   
 The inhibitory effect of EDB on 1,2-DCA was demonstrated.  In treatments in which both 
compounds were present, EDB was always consumed first and adversely impacted the 
kinetics of 1,2-DCA utilization.  In separate experiments with 1,2-DCA provided alone, 
dechlorination of 1,2-DCA was interrupted by adding EDB at a concentration more than 
100 times lower than the remaining 1,2-DCA; use of 1,2-DCA did not resume until the 
EDB decreased close to its MCL.   
 Experiments performed on low concentrations of EDB and 1,2-DCA (representative of 
environmental levels at leaded gasoline spills) demonstrated that the culture enriched on 
1,2-DCA had better potential for bioaugmentation. Compared with the EDB enrichment 
culture, the 1,2-DCA culture had the advantage of more rapid transition to 1,2-DCA after 
EDB was consumed.   
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Overall, the results of this study contribute to a general understanding of dehalogenation of 
chlorinated and brominated compounds. 
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TABLE 
 
Table 2.1Treatments Evaluation for the High Concentration Experiments. 
Treatment Compound(s) Added Inoculum 
A 1,2-DCA 1,2-DCA EC
a
 
B 1,2-DCA + EDB 1,2-DCA EC 
C 1,2-DCA EDB EC 
D 1,2-DCA + EDB EDB EC 
E EDB 1,2-DCA EC 
F EDB EDB EC 
a
 EC = enrichment culture 
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FIGURES 
 
Figure 3.1Representative results for biodegradation of 1,2-DCA in treatment A (a); 
biodegradation of EDB in treatment F (b); biodegradation of 1,2-DCA and EDB in treatment B 
(c); and biodegradation of 1,2-DCA and EDB treatment D (d).  Replicates are shown in 
Supporting Information.  Each arrow indicates addition of 0.31 mmol lactate.  
25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2The data in panel a correspond to the four panels in Figure 3.1; b corresponds to 
Figure 3.1a and 3.1c; and c is for bottles shown in Supporting Information.  Lines represent the 
model fit. Treatments are described in Table 2.1.  
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Figure 3.3  Summary of average ߤ̂    (a ), KS  (b), St  values (c), and lag times (d) for 1,2-DCA and 
EDB in enrichment cultures grown on 1,2-DCA and EDB.  Treatments are defined in Table 2.1.  
Error bars represent the standard deviation for 6-14 bottles per treatment. 
. 
 
 
 
  
0
30
60
90
A B C D B D E F
La
g 
tim
e 
(d
ay
s)
High Conc. 
(1,2-DCA)
Environ. Conc. 
(1,2-DCA)
0
5
10
15
0
50
100
150
A B C D B D E F
S t
fo
r E
D
B 
(µ
g/
L)
S t
fo
r D
CA
 (µ
g/
L)
1,2-DCA EDB
0.00
0.20
0.40
0.60
0.80
1.00
0
5
10
15
20
A B C D B D E F
E
DB
 K
S
(m
g/
L)
1,
2-
DC
A 
K S
(m
g/
L)
1,2-DCA EDB
 
a b
c d
High Conc. 
(1,2-DCA)
Environ. Conc. 
(1,2-DCA)
High Conc. 
(EDB)
Environ. Conc. 
(EDB)
0.0
0.2
0.4
0.6
0.8
A B C D B D E F
μm
ax
 (d
ay
-1
)
1,2-DCA EDB
.
01
02
03
ED
B 
K S
(m
g/
L)
27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4Representative results for the effect of EDB added to the enrichment culture 
biodegrading high levels of 1,2-DCA with no EDB added (a); 370 µg/L EDB added (b); and 645 
µg/L EDB added (c).  Each arrow indicates addition of 0.31 mmol lactate.  Replicate bottles are 
shown in Supporting Information.  EDB was added on day 16.5 and is shown in log scale (MCL 
= 0.05 µg/L).  
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Figure 3.5Biodegradation of environmental levels of 1,2-DCA or (and) EDB in an enrichment 
culture grown with 1,2-DCA as the terminal electron acceptor (a) and in an enrichment culture 
grown with EDB as the terminal electron acceptor (b). Each treatment was done in triplicates. 
Results for all the individual bottles are shown here.  Each arrow indicates addition of 0.25 mmol 
lactate. 
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Appendix-1:Pathway for 1,2-DCA and EDB Biodegradation Under Anaerobic Conditions 
 
The pathway for anaerobic reductive dehalogenation of 1,2-DCA and EDB is mentioned 
in the Introduction.  Figure A-1.1 shows the principal reductive dechlorination pathways for 1,2-
DCA.  The pathway for EDB is identical, with the substitution of bromine for chlorine.   
 
  CH2Cl - CH2Cl 
CH2 Cl - CH3 
CH3 - CH3 
2[H] 
HCl 
2[H] 
HCl 
CH2 = CH2 
CH2Cl = CH2 
2[H] 
2[H] 
2HCl 
2[H] 
HCl 
HCl 
(Abiotic) 
Figure A-1.16Pathways for anaerobic reduction of 1,2-DCA; [H] = H+ + e-. The pathways for 
anaerobic transformation of EDB are identical. 
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Appendix-2:Enrichment Cultures 
 
In the Materials and Methods section, under “Enrichment Cultures” mention is made of 
routine monitoring data and maintenance procedures for the cultures.  The purpose of this 
appendixis to provide this information.   
A-2.1  Maintenance of Enrichment Cultures 
EDB and 1,2-DCA enrichment cultures were developed by in two 2.6 L glass reagent 
bottles. The bottles were placed in boxes to exclude light and incubated quiescently. Teflon-
faced rubber septa (35 mm) were used to seal the bottles. The septa were placed inside a plastic 
bottle cap with 24-33 holes drilled for sampling by syringe. The bottles were incubated 
horizontally to maintain contact between the liquid and the septa, to minimize diffusive losses 
through the holes in the septa. The septa were replaced approximately once per month.  The 
procedures used to maintain each enrichmentculture are described below.   
An enrichment culture that chlororespires all of the chlorinated ethenes was used as the 
inoculum and 1,2-DCA or EDB were fed to the corresponding enrichment cultures. The 1,2-
DCA enrichment culture was fed weekly by injecting 30 μL of neat 1,2-DCA; the actual amount 
added was determined gravimetrically.  Each dose provided approximately 374 μmol per bottle 
and achieved an aqueous phase concentration of 0.24 mM (23.8 mg/L).  The stoichiometric 
amount of electron donor required for dihaloelimination to ethene was 0.748 millielectron 
equivalents per bottle.  To provide this plus a 75-fold excess (i.e., 55.7 millielectron equivalents 
per bottle), 1.9 mL of a sodium lactate stock solution (456.2 g/L of 60% sodium lactate syrup; 
2.44 mol/L) was added.  
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The EDB enrichment culture was fed weekly with 10 mLof EDB-saturated water. The 
actual dose (approximately 204μmol per bottle) was determined by headspace analysis on the gas 
chromatograph.  Initially, EDB was added as a neat liquid, in the same manner as 1,2-DCA.  
However, it tended to take so long for the EDB liquid to dissolve that the decision was made to 
switch to EDB-saturated water.  The large volume needed (i.e., 10 mL) was inconvenient but it 
solved the problem with reaching equilibration. This amount of EDB added resulted 
inapproximately the same aqueous phase concentration as 1,2-DCA, i.e., 0.13 mM(24.5 mg/L).  
Due to differences in molecular weights and Henry’s law constants, achieving the same aqueous 
phase concentratin resulted in adding a different total amount of EDB, i.e., 204 μmol per bottle 
of EDB per dose versus 374 μmol per bottle per dose of 1,2-DCA.  Thestoichiometric amount of 
electron donor required for dihaloelimination of each dose of EDB to ethene was 0.408 
millielectron equivalents per bottle.A dose of 0.67 mL per bottle of lactate was added to the EDB 
enrichment culture, providing 19.6 millielectron equivalents, or a 50-fold excess.   
After four additions of 1,2-DCA were consumed, 150 mL of the mixed culture was 
removed and replaced with MSM.  After three additions of EDB, 200 mL of the mixed culture 
was removed and replaced with MSM.  This action prevented the build-up of headspace gas 
pressure (from ethene and methane) and the accumulation of salts (from neutralization of HCl 
and HBr with NaOH) in the liquid. Every time a certain amount of enrichment culture was used 
for inoculation to start an experiment, the same volume of MSM was added in compensation. 
A-2.2  Monitoring Data for the Enrichment Cultures 
The performance of the 1,2-DCA enrichment culture over the period of time when it was 
used during this study is shown in Figure A-2.1.  The predominantdehalogenation product was 
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ethene; minor amount of ethane and VC also accumulated.  The percent recovery of daughter 
products is provided in section5.0.  
The performance of the EDB enrichment culture over the period of time when it was used 
during this study is shown in Figure A-2.2.  The predominant dehalogenation product was 
ethene; minor amount of ethane and VC also accumulated.  The percent recovery of daughter 
products is provided inAppendix section 5. 
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Figure A-2.17Data for 1,2-DCA enrichment culture maintenance. 
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Appendix-3:Magnitude of Electron Donor Additions 
 
In the Materials and Methods section, under “Batch Kinetics at High Concentrations”, 
mention is made of providing lactate in considerable excess of the amount needed for 
stoichiometric reduction of 1,2-DCA and EDB.  It was also stated that acetate and propionate 
were the major organic acids that accumulated. The purpose of this section of the Appendix is to 
provide documentation of this assessment.  
 Figure A-3.1a shows the ratio of the cumulativeelectron donor equivalents (eeq) of 
lactate added to the cumulative electron acceptor equivalents needed for stoichiometric reduction 
of 1,2-DCA and EDB.  Each curve represents a single bottle from each treatment; results for the 
other bottles were similar.  The ratio ranged from 15 at the start of the incubation to as high as 
177.Figure A-3.1b provides a summary of average ratio based on results from all the bottles in 
each treatment over the whole incubation period, as well as the minimum and the maximum 
ratio. 
 Figure A-3.2 shows the disposition of lactate that was added to four bottles:  two from 
treatment A (inoculated with the 1,2-DCA enrichment culture and supplied with 1,2-DCA as the 
electron acceptor) and two from treatment F (inoculated with the EDB enrichment culture and 
supplied with 1,2-DCA as the electron acceptor), over the first 6.5 days of incubation.  The 
cumulative amount of lactate added is shown as a step function; this was calculated based on the 
volume and concentration of the lactate stock solution.  Also shown are the amounts of acetate, 
propionate and remaining lactate, based on HPLC measurements of filtered (0.45 µm) samples.  
As expected, there was a significant level of lactate consumption (based on the difference 
between the amount added and the measured amount remaining).  By the end of the monitoring 
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period, the sum of the concentration of the three tested organic acids was close to the cumulative 
lactate concentration added (i.e., 22-24 mM), indicating a stoichiometric fermentation of lactate 
to acetate and propionate.   
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Appendix-4:Evaluation of Strategies for Adding 1,2-DCA and EDB 
 
In the Materials and Methods section, under “Batch Kinetics at High Concentrations”, 
mention is made of the strategy used to add 1,2-DCA and EDB for the high concentration kinetic 
tests.  The selection of anaddition method was based onseveral preliminary tests, which are 
covered in this section of the Appendix.  A variety of methods were explored.Resultsforfour 
approachesareshown in Figure A-4.1 for 1,2-DCA and Figure A-4.2 for EDB.  Monitoring data 
for two representative bottles are shown in each figure.  
One of the methods tested with 1,2-DCA was an initially moderate dose, followed by 
repeated additions to 40-50 µmol/bottle over the incubation period (Fig. A-4.1, panels a and b).  
A second approach was to add a lower initial dose followed by gradually increasing doses (Fig. 
A/4.1c) or a single high dose (Fig. A-4.1d), so that the highest amount added wasabove 500 
µmol/bottle. A third approach evaluated was to provide a highinitial dose (90-110 µmol/bottle) 
and no others (Fig. A-4.1, panels e and f).  The fourth strategy was to provide a low initial dose, 
followed by repeated additions at increasing doses (Fig. A-4.1, panels g and h).  This strategy 
was selected since it did not cause inhibition at the start (due to high initial concentrations), yet 
allowed for subsequent addition of high enough concentrations to capture the maximum growth 
rate and half saturation coefficient.   
Figure A-4.2 shows of the same strategies for EDB addition, although the initial amounts 
and highest amounts added were generally lower than for 1,2-DCA.  As with 1,2-DCA, the 
fourth approach (i.e., a low initial dose, followed by repeated additions at increasing doses) was 
adopted since it avoided problems caused by inhibition with high initial concentrations, yet 
allowed for quantification of the maximum growth rate and half saturation coefficient.   
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Method (d) in Figure A-4.2 proved to be suitable. This is analogous to the addition 
pattern selected for 1,2-DCA, with one exception that the highest EDB level present in the bottle 
was not allowed to exceed 50 µmol/bottle due to an observed inhibitory effect. 1,2-DCA can be 
increased to more than 100 µmol/bottle without an inhibitory effect. 
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Figure  A-4.111Comparison of different patterns of 1,2-DCA addition; see the text for a description 
of the feeding strategy for each panel.  Arrows indicate lactate additions. 
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Figure  A-4.212Comparison of different patterns of EDB; see the text for a description 
of the feeding strategy for each panel .  Arrows indicate lactate additions. 
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Appendix-5:Percent Recoveries of Ethene, VC, VB and Methane 
 
In the Results section, under “High Concentrations of 1,2-DCA and EDB”, mention is 
made of the percent recoveries of daughterproducts from 1,2-DCA and EDB dehalogenation, as 
well as the amount of methane formed. This section of the Appendixprovides the supporting 
information for theseassessments.  
FigureA-5.1a shows the percent recovery of ethene.  It was calculated by dividing the 
total amount of ethene formed by the total amount of 1,2-DCA and EDB consumed, on a molar 
basis.  Recoveries ranged from 65.1-77.6%.  FigureA-5.1b shows the maximum amount of VC 
and VB that accumulated in each treatment.  The percentages were calculated based on the 
highest amount of VC or VB that accumulated over the entire incubation period, divided by the 
total amount of 1,2-DCA and EDB consumed, respectively, on a molar basis.  The percentages 
ranged from 0.40% to 0.68% for VC, and 0.052% to 0.093% for VB.  Figure A-5.1c shows the 
amount of methane formed.  These values were calculated based of the electron equivalents of 
methane formed (moles of methane * 8 eeq/mole) divided by the electron equivalents of lactate 
added (moles of lactate * 12 eeq/mole), during the time periods when 1,2-DCA or EDB were 
being consumed.  All of the treatments are less than or equal to 1%, indicating very significant 
inhibition of methanogenesis.   
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Appendix-6:Comprehensive Results for theHigh Concentration Testswith1,2-DCA and EDB 
 
In the Results section, under “High Concentrations of 1,2-DCA and EDB”, results are 
presented for representative bottles in treatments A, B, D and F (Figure 3.1).  The purpose of this 
section of the Appendixis to present the results for all of the bottles that were used in the kinetic 
analyses.   
Results for treatment A are shown in Figures A-6.1, A-6.2, and A-6.3.   
Results for treatment B are shown in Figure A-6.4. 
Results for treatment C are shown in Figures A-6.5 and A-6.6. 
Results for treatment D are shown in Figure A-6.7. 
Results for treatment E are shown in Figure A-6.8 and A-6.9 
Results for treatment F are shown in Figures A-6.10 and A-6.11. 
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Figure A-6.114Results for treatment A, (a) bottle #1; (b) bottle #2; (c) bottle #3; and (d) bottle 
#4. 
a b 
d c 
48 
 
  
Figure A-6.215Results for treatment A, (a) bottle #73; (b) bottle #74; (c) bottle #75; and (d) 
bottle #76. 
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Figure A-6.316Results for treatment A, (a) bottle #A1; (b) bottle #A2; and (c) bottle #A3. 
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Figure A-6.417Results for treatment B, (a) bottle #24; (b) bottle #90; (c) bottle #100; (d) 
bottle #109; (e) bottle #110; and (f) bottle #99. 
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Figure A-6.518Results for treatment C, (a) bottle #85; (b) bottle #86; (c) bottle #87; (d) bottle 
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Figure A-6.619Results for treatment C, (a) bottle #C1; (b) bottle #C2; and (c) bottle #C3. 
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Figure A-6.720Results for treatment D, (a) bottle #60; (b) bottle #105; (c) bottle #106; (d) 
bottle #113; (e) bottle #93; and (f) bottle #94. 
0
0
0
0
0
1
1
1
1
1
1
0
20
40
60
80
100
120
140
160
180
200
0 10 20 30 40 50
E
th
e
n
e
, M
e
th
a
n
e
, 
V
C
, 
V
B
 
(u
m
o
l/
b
o
tt
le
)
1
,2
-D
C
A
, 
E
D
B
 (
μ
m
o
l/
b
o
tt
le
)
Time (days)
1,2-DCA EDB VC Ethene Methane VB
a b 
d c 
e 
f 
54 
 
 
 
  
0.00
0.01
0.02
0.03
0.04
0
5
10
15
20
25
30
35
40
0 10 20 30 40
V
B
 (
µ
m
o
l/
b
tl
)
E
D
B
, 
E
th
e
n
e
, 
C
H
4
 (
μ
m
o
l/
b
tl
)
Time (days)
0.00
0.02
0.04
0.06
0.08
0.10
0
10
20
30
40
50
60
0 10 20 30 40 50
V
B
 (
µ
m
o
l/
b
tl
)
E
D
B
, 
E
th
e
n
e
, 
C
H
4
 (
μ
m
o
l/
b
tl
)
Time (days)
0.00
0.02
0.04
0.06
0.08
0.10
0
10
20
30
40
0 10 20 30 40
V
B
 (
µ
m
o
l/
b
tl
)
E
D
B
, 
E
th
e
n
e
, 
C
H
4
 (
μ
m
o
l/
b
tl
)
Time (days)
0.00
0.01
0.02
0.03
0.04
0
10
20
30
40
50
0 10 20 30
V
B
 (
µ
m
o
l/
b
tl
)
E
D
B
, 
E
th
e
n
e
, 
C
H
4
 (
μ
m
o
l/
b
tl
)
Time (days)
0.00
0.01
0.02
0.03
0.04
0.05
0
10
20
30
40
50
0 10 20 30
V
B
 (
µ
m
o
l/
b
tl
)
E
D
B
, 
E
th
e
n
e
, 
C
H
4
 (
μ
m
o
l/
b
tl
)
Time (days)
Figure A-6.821Results for treatment E, (a) bottle #60; (b) bottle #105; (c) bottle #106; (d) 
bottle #113; (e) bottle #93; and (f) bottle #94. 
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Figure A-6.922Results for treatment E, (a) bottle E1; (b) bottle #E2; (c) bottle #E3. 
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Figure A-6.1023Results for treatment F, (a) bottle #42; (b) bottle #43; (c) bottle #44; (d) bottle 
#101; (e) bottle #111; and (f) bottle #112. 
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Figure A-6.1124Results for treatment F,  (a) bottle #F1; (b) bottle #F2; and (c) bottle #F3. 
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Appendix-7:Mineral Medium Controls and Water Controls 
 
In the Results section, under “High Concentrations of 1,2-DCA and EDB”, mention is 
made of the results for mineral medium controls and water controls.  The purpose of this  section 
of the Appendixis to present these results. 
Figure A-7.1 shows the results for the medium controls.  Different amounts of 1,2-DCA 
and EDB were evaluated.  One set of controls contained 1,2-DCA and EDB at levels close to 
those at gasoline spill sites, which were used in the low concentration experiments (i.e., ~4 
µmol/bottle of 1,2-DCA, or 4 mg/L; ~1 µmol/bottle of EDB, or 2 mg/L).  There was no 
substantial decrease in 1,2-DCA during 124 days of incubation, while there was a modest loss of 
EDB after day 47-55.  At an intermediate levels (i.e., ~23 µmol/bottle of 1,2-DCA, or 22 mg/L; 
~21 µmol/bottle of EDB, or 39 mg/L), decreases in 1,2-DCA became noticeable after day 103-
178, while EDB showed a noticeable decrease after day 75-140. In medium controls with 1,2-
DCA alone at high levels (96 µmol/bottle, or 92 mg/L), losses became noticeable after day 109.  
In the treatment with both 1,2-DCA and EDB present (i.e., ~90-109 µmol/bottle of 1,2-DCA, or 
87-105 mg/L; ~56-57 µmol/bottle of EDB, or 103-105 mg/L), losses of 1,2-DCA became 
noticeable after day 35-53, while EDB showed no significant change during the 60 days of 
incubation. 
Figure A-7.2 shows the results for the EDB water controls; water controls for 1,2-DCA 
were not prepared.  The bottles were sampled only twice.  Over the 80 days of incubation, no 
significant losses occurred.    
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Figure A-7.125Results for the mineral medium controls. 
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Figure A-7.226Results for the EDB water controls. 
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Appendix-8:ComprehensiveResults for Maximum Growth Rates 
 
In the Results section, under “High Concentrations of 1,2-DCA and EDB”, representative 
results are presented for how the maximum growth rates were determined for treatments A, B, D 
and F (Figure 3.2a).  The purpose of this section of the Appendixis to present the results for all of 
the bottles that were used to measure  . 
Average values and standard deviationsfor each treatment are provided in TablesA-8.1 to 
A-8.9. 
Individual bottle results for treatment A are shown in Figures A-8.1 and A-8.2.   
Individual bottle results for treatment B are shown in Figure A-8.3. 
Individual bottle results for treatment C are shown in Figures A-8.4 and A-8.5. 
Individual bottle results for treatment D are shown in Figure A-8.6. 
Individual bottle results for treatment E are shown in Figure A-8.7. 
Individual bottle results for treatment F are shown in Figures A-8.8 and A-8.9. 
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Table A-8.12MaximumGrowth Rates for 1,2-DCA 
Treatment Substrate(s)/Culture   (d-1) No. of runs 
A DCA/DCA 0.5091±0.0662
a
 8 
B DCA+EDB/DCA 0.5763±0.0918 4 
C DCA/EDB 0.5346±0.0833 6 
D DCA+EDB/EDB 0.1873±0.0231 2 
a
Standard deviation. 
 
 
Table A-8.23MaximumGrowth Rates for EDB 
Treatment Substrate(s)/Culture   (d-1) No. of runs 
B EDB+DCA/DCA 0.3537 ± 0.0209
a
 5 
D EDB+DCA/EDB 0.4020 ± 0.0483 4 
E EDB/DCA 0.5427 ± 0.0642 5 
F EDB/EDB 0.4539 ± 0.0697 6 
a
Standard deviation. 
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Figure A-8.128Results for 1,2-DCA in treatment A, (a) bottle #1; (b) bottle #2; (c) bottle #3; 
and (d) bottle #4. 
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Figure A-8.229Results for 1,2-DCA in treatment A, (a) bottle #73; (b) bottle #74; (c) bottle 
#75; and (d) bottle #76. 
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Figure A-8.330Results for 1,2-DCA in treatment B, (a) bottle #99; (b) bottle #100; (c) bottle 
#109; and (d) bottle #110. 
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Figure A-8.431Results for EDB in treatment B, (a) bottle #24; (b) bottle #90; (c) bottle #10; 
(d) bottle #109; and (e) bottle #110. 
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Figure A-8.532Results for 1,2-DCA in treatment C, (a) bottle #85; (b) bottle #86; (c) bottle 
#87; (d) bottle #102; (e) bottle #103; and (f) bottle #104. 
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Figure A-8.633Results for 1,2-DCA in treatment D, (a) bottle #96; and (b) bottle #94. 
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Figure A-8.734Results for EDB in treatment D, (a) bottle #60; (b) bottle #105; (c) bottle #106; 
and (d) bottle #113. 
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Figure A-8.835Results for EDB in treatment E, (a) bottle #80; (b) bottle #97; (c) bottle #98; 
(d) bottle #107; and (e) bottle #108. 
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Figure A-8.936Results for EDB in treatment F, (a) bottle #42; (b) bottle #43; (c) bottle #44; 
(d) bottle #101; (e) bottle #111; and (f) bottle #112. 
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Appendix-9:Comprehensive Results for KS, St and  
 
In the Results section, under “High Concentrations of 1,2-DCA and EDB”, representative 
results are presented for how the half saturation coefficients, transition concentrations, and 
maximum substrate utilization rates were determined for treatments A, B, D and F (Figure 3.2, 
panels b and c).  The purpose of this section of the Appendixis to present the results for all of the 
bottles that were used to measure KS, St, and   . 
Average values and standard deviations for each treatment are provided in Table A-9.1 to 
Table A-9.12. 
Individual bottle results for treatment A are shown in Figures A-9.1 and A-9.2.   
Individual bottle results for treatment B are shown in Figures A-9.3 and A-9.4. 
Individual bottle results for treatment C are shown in Figures A-9.5 and A-9.6. 
Individual bottle results for treatment D are shown in FiguresA-9.7 and A-9.8. 
Individual bottle results for treatment E are shown in FiguresA-9.9 and A-9.10. 
Individual bottle results for treatment F are shown in Figures A-9.11 and A-9.12. 
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Table A-9.14Results for KS, St and   
Treatment 
  
(mg/L/d) 
Ks 
(mg/L) 
St 
(µg/L) No. of runs 
A 13.9   ±   4.4
a
 8.439   ±   0.044
a
 38.28   ±   6.29
a
 11 
B 15.4   ±   7.8 15.679   ±   0.064 28.84   ±   4.29 6 
C 10.9   ±   3.2 5.724   ±  0.044 12.85   ±   3.82 9 
D 6.0   ±   1.0 12.366   ±   0.027 127.48   ±   5.19 2 
B 11.0   ±   4.7 8.78E-03   ±   0.0132 0.691   ±   0.844 6 
D 20.1   ±   3.3 1.54E-02   ±   0.0059 9.184   ±   2.842 5 
E 9.5   ±   3.4 7.75E-05   ±   0.0031 5.264   ±   3.379 8 
F 17.3   ±   4.7 8.37E-01   ±   0.0157 0.495  ±   0.519 8 
a
Standard deviation. 
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Figure A-9.137Results for 1,2-DCA in treatment A, (a) bottle #1; (b) bottle #2; (c) bottle #3; 
(d) bottle #4; (e) bottle #73 and (f) bottle #74. 
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Figure A-9.238Results for 1,2-DCA in treatment A, (a) bottle #75; (b) bottle #76; (c) bottle 
#A1; (d) bottle #A2 and (e) bottle #A3. 
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Figure A-9.339Results for 1,2-DCA in treatment B, (a) bottle #24; (b) bottle #90; (c) bottle 
#99; (d) bottle #100; (e) bottle #109 and (f) bottle #110. 
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Figure A-9.440Results for EDB in treatment B, (a) bottle #24; (b) bottle #90; (c) bottle #99; 
(d) bottle #100; (e) bottle #109 and (f) bottle #110. 
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Figure A-9.541Results for 1,2-DCA in treatment C, (a) bottle #85; (b) bottle #86; (c) bottle 
#87; (d) bottle #102; (e) bottle #103 and (f) bottle #104. 
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Figure A-9.642Results for 1,2-DCA in treatment C, (a) bottle #C1; (b) bottle #C2 and (c) 
bottle #C3. 
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Figure A-9.743Results for 1,2-DCA in treatment D, (a) bottle #93 and (b) bottle #94. 
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Figure A-9.844Results for EDB in treatment D, (a) bottle #93; (b) bottle #94; (c) bottle #105 
and (d) bottle #113. 
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Figure A-9.945Results for EDB in treatment E, (a) bottle #80; (b) bottle #97; (c) bottle #98; 
(d) bottle #107; (e) bottle #108 and (f) bottle #E1. 
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d c 
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Figure A-9.1046Results for EDB in treatment E, (a) bottle #E2 and (b) bottle #E3. 
a 
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Figure A-9.1147Results for EDB in treatment F, (a) bottle #101; (b) bottle #111; (c) bottle 
#112; (d) bottle #F1; (e) bottle #F2 and (f) bottle #F3. 
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Figure A-9.1248Results for EDB in treatment F, (a) bottle #FY1 and (b) bottle #FY2. 
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Appendix-10:Effect of Ston KS 
 
In the Discussion section, mention is made about the effect of includingtransition 
concentrations (St) on the fitting results of Monod half saturation coefficients (KS). This section 
provides a comparison betweenKS values when St was and was not included. KS and its 
coefficient of variation (cv = standard deviation divided by the value) are provided in Table A-
10.1. 
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Table A-10.15Effect of Including St in the Monod Equation on the Fitting Results for KS 
Treatment 
1,2-DCA EDB 
with St without St 
with St 
without St 
KS cv KS cv KS cv KS cv 
A 8.439 0.52% 8.80 0.54% - - - - 
B 15.679 0.41% 17.3 0.37% 8.78E-03 150% 3.35E-05 39487% 
C 5.724 0.77% 5.73 0.80% - - - - 
D 12.366 0.22% 22.6 0.60% 1.54E-02 38.5% 4.57E-05 10373% 
E - - - - 7.75E-05 3949% 3.22E-05 8843% 
F - - - - 8.37E-01 2% 8.78E-01 2% 
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Appendix-11:Biomass Levels Based on Protein Concentrations 
 
Mention was made about measurement of biomass concentrations based on protein, both 
in the Materials and Method section under “Batch Kinetics at High Concentrations”, and in the 
Results section under “High concentrations of 1,2-DCA and EDB”. This appendix provides the 
results for the protein analyses. 
 In order to measure protein over time, aseparate setof bottles wasprepared with the same 
headspace versus aqueous phase volume ratio as used in the serum bottles, but with the bottle 
size increasedto 1 liter.  This allowed for frequent sample removal for protein 
measurementwithoutsignificantly affecting the liquid-to-headspace ratio in the bottles. The 
amounts of inoculum and substrates added were increased proportionately to the serum bottles, 
andthe same feeding procedure for 1,2-DCA, EDB and lactate was followed. Duplicate bottles 
were prepared for treatments A, C, E, and F.  Protein was measured as described in section 2.2.   
The concentration of protein for each treatment is shown in Figure A-11.1, along with the 
1,2-DCA and EDB data that were used to determine KS, St and   .  As indicated in the test, there 
was no significant change in protein concentrations during this time interval, lending support for 
the assumption the biomass concentration had reached a maximum.   
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Figure A-11.149Protein results for (a) treatment A, bottle #1; (b) treatment A, bottle #2; (c) 
treatment C, bottle #1; (d) treatment C, bottle #2; (e) treatment E, bottle #1; (f), treatment E, bottle 
#2; (g) treatment F, bottle #1; and (h) treatment F, bottle #2. 
 
a b 
d c 
e f 
g h 
Treatment A #1 Treatment  #2 
Treatment C #1 Treatment C #2 
Treatment E #1 Treatment E #2 
Treatment F #1 Treatment F #2 
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Appendix-12:Effect of Low EDB Levels on the Rate of 1,2-DCA Dechlorination 
 
In the manuscript, results for only one of the duplicates in the test of “Effect of low EDB 
levels on 1,2-DCA” are shown in Figure 3.4.  The purpose of this Appendix is to provide the 
results for the duplicate bottles.  As shown in Figure A-12.1, the results are similar to what are 
shown in Figure 3.4. 
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Figure A-12.150Representative for duplicate bottles showing the effect of EDB added to the 
enrichment culture biodegrading high levels of 1,2-DCA with no EDB added (a); 370 µg/L 
EDB added (b); and 645 µg/L EDB added (c).  Each arrow indicates addition of 0.31 mmol 
lactate.  Replicate bottles are shown in Figure 3.4.  EDB was added on day 16.5 and is 
shown in log scale (MCL = 0.05 µg/L). 
 
a 
 
b 
 
c 
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Appendix-13: GC Response Factors 
 
 Response factors for the volatile organic compounds monitored by gas chromatography 
with the flame ionization detector (FID) and the electron capture detector (ECD) are provided in 
Table A-13.1 and A-13.2, respectively.   
 
Table A-13.16GC Response Factors for Volatile Organic Compounds with the FID Detector 
Compound 
GC RT 
(min) 
FID Response Factor Conversion Factor
a
 Ref. for HC 
(corresponding 
temperature) 
µmol/bottle 
/PAU
b
 
R
2
 
µmol/bottle 
to µM 
µmol/bottle 
to µg/L 
Methane 0.59 2.014E-06 0.9988 0.5789 9.262 (27) (25°C) 
Ethene 0.86 1.168E-06 0.9998 1.8713 52.40 (26) (23°C) 
Ethane 0.95 9.700E-07 0.9998 0.8787 26.36 (26) (23°C) 
VC 3.17 2.703E-06 0.9992 6.2745 392.2 (40) (23°C) 
Chloroethane 3.93 4.593E-06 0.9992 7.9605 515.0 (40) (23°C) 
VB 4.91 4.570E-06 0.9910 7.6824 821.6 (28) (25°C) 
Bromoethane 5.55 7.064E-06 0.9999 8.4638 922.3 (27) (25°C) 
1,2-DCA 8.16 4.327E-05 0.9992 9.6920 959.1 (25) (23°C) 
EDB 12.46 8.610E-05 0.9999 9.8545 1843 (25) (23°C) 
 
a
Based on a liquid volume of 100 mL and a gas volume of 60 mLat respective temperatures. 
b
 PAU = peak area unit. 
 
 
Table A-13.27GC Response Factors for Volatile Organic Compounds with the ECD Detector 
Compound 
GC RT 
(min) 
ECD Response Factor Conversion Factor
a
 Ref. for HC 
(corresponding 
temperature) 
µmol/bottle 
R
2
 
µmol/bottle µmol/bottle 
/PAU
b
 to µM to µg/L 
1,2-DCA 13.1895 7.61E-06 0.9874 9.692 959.1 (25) (23°C) 
EDB 17.023 1.28E-07 0.9993 9.8545 1843 (25) (23°C) 
 
a
Based on a liquid volume of 100 mL and a gas volume of 60 mL at respective temperatures. 
b
 PAU = peak area unit. 
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